Sign in
4

Changes in Ownership

HERON THERAPEUTICS, INC. /DE/ Filed Acc 0001209191-21-060547

EVP, Drug Development gave up 433 shares (to pay taxes)

  • EVP, Drug Development acquired 1,250 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
MANHARD KIMBERLY EVP, Drug Development 2021-10-13 Option exercise +1,250 3,701 D
MANHARD KIMBERLY EVP, Drug Development 2021-10-13 Shares withheld for taxes −433 $10.55 $4,568 3,268 D
Derivatives
MANHARD KIMBERLY EVP, Drug Development 2021-10-13 Option exercise · Restricted Stock Units −1,250 15,000 D
MANHARD KIMBERLY EVP, Drug Development 2021-10-13 Grant or award · Employee Stock Option (Right to Buy) +92,200 92,200 D
MANHARD KIMBERLY EVP, Drug Development 2021-10-13 Grant or award · Restricted Stock Units +55,320 55,320 D
Loading xslF345X03/doc4.xml…